Skip to main content
. Author manuscript; available in PMC: 2014 May 2.
Published in final edited form as: Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007482. doi: 10.1002/14651858.CD007482.pub2
Methods RCT; 2 parallel groups.
Participants Dates of data collection:Not specified.
Setting: Fairfax Hospital, Virginia, US. Women predominantly private
Inclusion: criteria: high-risk women undergoing CS (in active labor and/or ruptured membranes > 4 hours); not consistent with the criteria for non-elective in this review:
classified as “both/undefined” in this review Exclusion: active infection, fever, antibiotic use within 3 days, allergy to penicillin or cephalosporins
Interventions Ceftizoxime 2 g (N = 50) vs placebo (N = 49) IV at time of cord clamping
Outcomes Febrile morbidity (oral temperature > 37.9°C twice at least 8 hr apart, after first 24 hr); endometritis (fever and foul lochia or uterine tenderness); UTI (fever and positive culture); wound infection (fever, abnormal-looking wound, surrounded by cellulitis and/or draining purulent material)
Notes Class of antibiotic: third generation cephalosporin.
There was 1 drug reaction (maculopapular rash) in the treatment group.
Women followed up at 6 weeks.
Subgroups:
  • type of CS unclear;

  • after cord clamping.

Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear “randomized.” Method not described.
Allocation concealment? Unclear No information.
Blinding? Unclear Placebo controlled.
All outcomes Described as “double-blinded” but insufficient information to judge whether there was adequate blinding of study personnel
Incomplete outcome data addressed? Unclear No loss of participants to follow up.
All outcomes 1 patient was removed from the study when she became febrile in the delivery room, not included in ITT analysis
Free of selective reporting? Unclear Insufficient information to judge.
Free of other bias? Unclear “The groups were comparable. No significant differences were observed between the 2 groups with respect to maternal age, parity, gestational age, duration of labor, duration of ruptured membranes or use of internal fetal monitoring. There were no significant differences regarding indication for CS”. There was insufficient other information which to judge
Overall low risk of bias? Unclear Mostly unclear.
HHS Vulnerability Disclosure